跳至主要内容
临床试验/NCT03002766
NCT03002766已完成2 期

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2000年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
224
试验地点
2
主要终点
Ipsilateral Breast Tumor Recurrence (IBTR)

研究概览

简要总结

By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins.

Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age >18 years;
  • female candidate to breast conservative surgery

排除标准

  • female with previous omolateral or controlateral breast cancer;
  • female with previous radiotherapy (RT).

结局指标

主要结局

Ipsilateral Breast Tumor Recurrence (IBTR)

时间窗: six years

次要结局

  • Contralateral breast cancer (CBC)(six years)

研究者

发起方
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验